Australia’s synthetic biology opportunity

By Heidi Heck · 9 November 2021 · News

Australia’s synthetic biology opportunity

Full details: Australia’s synthetic biology opportunity

See the complete version on Dynamic Business for the full story and insights.

Read the full article →

Summary

Dynamic business spoke with Phil Morle, a partner at Venture capital firm, Main Sequence, founded by CSIRO to talk about Australia’s opportunity to be a world leader in the field of synthetic biology. Who are you, and what does Main Sequence do? Phil: “I’m Phil Morle. I’m a partner at Main Sequence, a venture capital […]